Amro Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 02-07-2024
- Paid Up Capital ₹ 0.30 M
as on 02-07-2024
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
as on 02-07-2024
- Revenue 47.30%
(FY 2020)
- Profit 25.10%
(FY 2020)
- Ebitda 313.70%
(FY 2020)
- Net Worth 28.20%
(FY 2020)
- Total Assets 16.91%
(FY 2020)
About Amro Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹1.00 M.
Arvind Arora and Daljeet Singh serve as directors at the Company.
- CIN/LLPIN
U74120DL2009PTC192827
- Company No.
192827
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Aug 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Amro Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvind Arora  | Director | 03-Aug-2009 | Current |
| Daljeet Singh | Director | 03-Aug-2009 | Current |
Financial Performance and Corporate Structure Insights of Amro Pharma.
Amro Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 47.3% increase. The company also saw a substantial improvement in profitability, with a 25.1% increase in profit. The company's net worth Soared by an impressive increase of 28.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amro Pharma?
In 2019, Amro Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
20 years 9 months Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 20 Jan 2016 | ₹1.00 M | Open |
How Many Employees Work at Amro Pharma?
Unlock and access historical data on people associated with Amro Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Apr 27, 2011, Amro Pharma has raised a total of ₹ 0.2 M, with the most recent deal valued at ₹ 0.2 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
